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CORRESPONDENCE
The Awakening of Alice
Over the last 10 years, endovascular treatment of complex
aneurysms involving the visceral arteries and thoraco-
abdominal aortic segment has attracted considerable inter-
est within the vascular community, while also inevitably
raising expectations. Accordingly, the evolution of less inva-
sive technologies for treating a potentially lethal pathology
(which generally develops in frail, elderly patients), in
conjunction with dramatic improvements in stent graft
technology and intraoperative imaging strategies has led to
excellent presentations being delivered by clever and skilled
pioneers, one consequence of which has been a “temptation”
for the rest of the vascular surgical community to follow suit.
In this respect, we feel that the recent Editorial by Ver-
hoeven et al.,1 despite their expertise in this ﬁeld, has un-
derstated the true lessons to be learned regarding this
evolving technology. The Editorial’s basic message was that in
order to achieve the best results you must be a highly skilled
surgeon, with enormous experience, working in an expert
centre with an up-to-date hybrid room, equipped with the
best imaging facilities. To prove their point, they quote
recently published studies showing excellent short-term re-
sults, with a low perioperative mortality (2.4%), almost no
endoleaks, and a very high target vessel patency.2,3 Faced
with these statistics, who could possibly disagree? Unfortu-
nately, the Editorial’s message, albeit seductive, reminds us
of Alice in Wonderland, who fell asleep and then started to
dream of a wonderful magical world.
The reality, however, and as was observed in the inde-
pendently controlled Windows trial,4 is somewhat different
for the following reasons: (1) uncontrolled, self-reported
outcomes represent a poorer level of evidence, even if
the authors are thorough, honest, and hard working. Put
simply, they rarely reﬂect “real-life results”. (2) Very few
institutions have the time, ﬁnancial resources, or manpower
to gather such results. As surgeon’s job is primarily to treat
patients and improve surgical management or technology,
he may not be aware of patient’s clinical status changes,
even when careful follow-up visits are scheduled. (3) We
have learned from the Windows Trial that tracking patients
was very challenging, with more than 10% of patients being
lost within the system, only to be found after protracted
searching within academic institutional and/or family doctor
records or via either the patients families or the National
PMSI database. Of great importance, some of the “missing”
patients had died or suffered severe complications that had
gone unnoticed by the responsible centres. (4) It is (to us)
otherwise too simplistic to explain any less than favourable
results by simply blaming the learning curve.
To minimise any chances that the learning curve may
have compromised outcomes, the Windows Trial involved
(a) anatomical feasibility that was double-checked by an
independent core laboratory and the Cook core laboratory,
and (b) clinical technical support by an expert proctoring
surgeon was provided wherever necessary. Once the trial
was completed, it was found that there was no statistical
difference (in terms of mortality) between the two highest
volume centres (Lille and Creteil) and the ﬁve less experi-
enced ones.4
We also strongly believe that there is more to learn from
mistakes than from success. The Windows Trial enabled us
to identify risky procedures (despite strict selection criteria)
and to then ﬁnd ways of improving results. It also under-
lined the poor outcomes associated with postoperative
renal insufﬁciency, spinal cord ischaemia, as well as limb and
mesenteric ischaemia. Technical strategies have now been
developed to prevent these complications, such as high-
dose heparin, reducing the volume of contrast injections,5
or treating the patients in a two- or three-staged procedure.
From the Windows Trial, we also learned that the rejec-
tion rate of potential candidates for FEVAR and BEVAR (by
the participating centres) was up to 40%,4 raising the
difﬁcult question of what should be done for these pa-
tients? The authors of the Editorial almost omitted to
mention any alternative treatment options such as parallel
grafts, chimneys, snorkels, on-table fenestrations (and even
open surgery), all of which may offer a successful outcome
in difﬁcult or urgent cases. It is also important to be aware
that the cost-effectiveness of FEVAR and BEVAR over open
repair remains questionable.6 Finally, some patients are too
frail to undergo even one of these less invasive procedures.
A recent paper from Resch et al.7 has shown that 54% of
patients died during the 10-year period of study, suggesting
that “even if we can do it, should we?”
In conclusion, vascular surgeons (such as us) strongly
believe in the new development of endovascular approaches
for the treatment of complex aortic procedures. However,
important lessons must be learnt, and all of the alternative
techniques should be mastered before launching such a
programme. Otherwise surgeons and patients will face
exactly what Alice faced when she awakened: the dull reality.
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Response to “Re: The Awakening of Alice”
It was with great interest that I read the various comments
from Jean-Pierre Becquemin and his colleagues in response to
our recent editorial.1,2 I agree with the authors that it is oc-
casionally difﬁcult to match results produced from high-
volume expert centers in the “real world”. Examples include
the “Bolia subintimal angioplasty technique” or (more rele-
vant to this debate) the results of open thoracoabdominal
aortic aneurysm (TAAA) surgery. However, it is still our pri-
mary task to provide the best possible patient care, especially
in pathologies that require more complex surgery.
If one wishes to embark on treating TAAAs with fenes-
trated and/or branched grafts, a number of prerequisites are
necessary. These include (i) dedicated surgeons who want to
invest in these techniques in order to acquire much-needed
expertise; (ii) perfect organization with regard to logistics,
including access to a hybrid room; and (iii) the creation of a
professional team, including anesthesiologists and nurses.
While I agree that not all of these prerequisites require a
high-volume center, there should be no doubt that this type
of complex pathology is best treated in large-volume centers.
There is simply no place for amateur behaviour or inexperi-
enced operators, as even minor technical errors can be costly
to the patient, as we have all experienced.
Pioneers have to take new techniques forward and should
report their results. In order to help others move forward,
we fully agree with the authors that these reports should
provide more detail regarding indications, limitations and
lessons learned. Fenestrated endovascular aortic aneurysm
repair (FEVAR) has become a standardized technique in our
center, with low mortality and excellent midterm results. We
also agree that follow-up should be enforced, and the fact
that so many patients were not followed up in the Windows
trial could be interpreted as a lack of organization and
dedication. Our paper on 10 years of experience in TAAA
branched grafting concluded that “too high-risk” patients
should not be treated at all. Indeed, the highest-risk patients
had a higher early mortality and lower survival.3 We also
agree that patients who are unlikely to survive for 2 years
after their surgery will not (by deﬁnition) have beneﬁtted
from the repair. Our conclusion in that article was meant to
help other centers. Obviously, it is difﬁcult for surgeons to
deny a patient treatment when he or she has been referred
as “a last resort”, but we have to learn from experience and
help others not to make the same mistakes.
It was a little disappointing that the authors considered
our published work to be of lower evidential quality
(compared with the Windows trial). They have reported that
there was no statistical difference in mortality between the
two high-volume and the other ﬁve centers in the Windows
trial, but (by their own criteria) this type of post-hoc anal-
ysis is also “lower-quality evidence” as the numbers are too
small to enable any meaningful comparison. A non-
inferiority study would require about 600 patients in each
arm to prove that the lack of difference was not due to a
type II error. In other words, the Windows Registry was
never powered to prove this statistical difference.
Our caveat emptor editorial was intended to warn col-
leagues about problems associated with uncritically devel-
oping endovascular programmes for treating complex TAAAs
and to motivate them to invest more in organization, logistics,
and team approaches. Dedicated endovascular teams can
perform standard FEVAR after thorough training, even in
lower-volume centers. However, for triple and quadruple
FEVAR cases, the imaging requirements are clearly higher
(longer ﬂuoroscopy times, including lateral viewing) and the
operative risks inevitably increase. For cases of branched TAAA,
all of the prerequisites discussed above should bemet in order
to address numerous potential intraoperative complications. It
is, therefore, shameful that politics and/or professional orga-
nizations are not able (or unwilling) to promote the centrali-
zation of treatment for patients with complex aortic pathology.
As Holt and Thompson recently stated: “if we fail to centralize
complex aortic pathology, we will have failed our patients”.4
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